RYTM vs STE · rev $130.1M vs P/E 25, rev $5.46B
Rhythm Pharmaceuticals Inc (RYTM) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
RYTM currently screens at market cap $6.49B. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the RYTM and STE stock pages for the full models.
Not investment advice.